Special Reports The 10 most-anticipated drug launches of 2020

Special Reports The 10 most-anticipated drug launches of 2020

Multiple Sclerosis Update: Biogen, Sanofi, Active, Adamas and Novartis

Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!! Earlier this week, Active Biotech, based in Lund, Sweden, announced that it was abandoning its neurology focus, including MS. The overall focus is on the company’s wholly-owned lead assets, laquinimod and tasquinimod. Laquinimod is an oral small molecule developed primarily for … Συνεχίστε να διαβάζετε Multiple Sclerosis Update: Biogen, Sanofi, Active, Adamas and Novartis.

Roche SMA therapy granted speedy FDA review; decision by May 2020

Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!!  Dive Brief: The Food and Drug Administration will give Roche's experimental therapy for spinal muscular atrophy a speedy review and will decide on approval within six months, the Swiss pharma​ said Monday. If approved, Roche's risdiplam would be the third SMA therapy … Συνεχίστε να διαβάζετε Roche SMA therapy granted speedy FDA review; decision by May 2020.

Clinical Catch-Up for the First Week of July

Clinical Catch-Up for the First Week of July

Can Gene Therapy Become The Cure For Blindness?

  Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!!    With the first gene therapy for blindness in the market, the door has been opened for a new wave of gene therapy treatments with the potential to cure genetic blindness.  In December 2017, the FDA approved Luxturna, the first … Συνεχίστε να διαβάζετε Can Gene Therapy Become The Cure For Blindness?.

Top 15 Best-Selling Drugs of 2018

Top 15 Best-Selling Drugs of 2018